Irland - engelsk - HPRA (Health Products Regulatory Authority)

octapharma limited - albumin human - solution for infusion - 50 g/l

Irland - engelsk - HPRA (Health Products Regulatory Authority)

instituto grifols s.a. - human albumin - solution for infusion - 200 gram(s)/litre - blood substitutes and plasma protein fractions; albumin

USA - engelsk - NLM (National Library of Medicine)

csl behring ag - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 12.5 g in 50 ml - since the oncotic pressure of alburx® 25, albumin (human) 25% solution is about four times higher than that of normal human serum, it will expand the plasma volume if interstitial water is available for an inflow through the capillary walls. however, many patients suffering from an acute volume deficit also have some degree of interstitial dehydration. in the absence of hyperhydration, the treatment of an acute volume deficit with alburx® 25 should therefore include isotonic electrolyte solutions with an albumin:electrolyte ratio of 1:3 or 1:4. by contrast, chronic volume deficits have usually been at least partially compensated for by the renal retention of sodium and water with some degree of tissue edema, and in these circumstances a trial with alburx® 25 only is indicated. in any case, an anemia of clinically relevant magnitude requires specific treatment, and the metabolic needs of the patient with respect to fluid and electrolytes must be cared for. the common causes of hypoproteinemia are protein-ca

USA - engelsk - NLM (National Library of Medicine)

kedrion biopharma, inc. - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 10 g in 50 ml - emergency treatment of hypovolemic shock albuked 20 is hyperoncotic and on intravenous infusion will expand the plasma volume by an additional amount, three to four times the volume actually administered, by withdrawing fluid from the interstitial spaces, provided the patient is normally hydrated interstitially or there is interstitial edema.(1) if the patient is dehydrated, additional crystalloids must be given,(4) or alternatively, albumin (human) 5%, usp (albuked™ 5) should be used. the patient’s hemodynamic response should be monitored and the usual precautions against circulatory overload observed. the total dose should not exceed the level of albumin found in the normal individual; i.e., about 2 g per kg body weight in the absence of active bleeding. although albuked 5 is to be preferred for the usual volume deficits, albuked 20 with appropriate crystalloids may offer therapeutic advantages in oncotic deficits or in long-standing shock where treatment has been delayed.(2) removal of ascitic fluid from a

Malta - engelsk - Medicines Authority

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - human albumin, solution - solution for infusion - human albumin solution 200 g/l - blood substitutes and perfusion solutions

Malta - engelsk - Medicines Authority

csl behring gmbh emil-von-behring-strasse 76, 35041 marburg, germany - human albumin, solution - solution for infusion - human albumin solution 50 g/l - blood substitutes and perfusion solutions

Malta - engelsk - Medicines Authority

csl behring gmbh emil-von-behring-strasse 76, 35041 marburg, germany - human albumin, solution - solution for infusion - human albumin solution 50 g/l - blood substitutes and perfusion solutions

Malta - engelsk - Medicines Authority

csl behring gmbh emil-von-behring-strasse 76, 35041 marburg, germany - human albumin, solution - solution for infusion - human albumin solution 50 g/l - blood substitutes and perfusion solutions

Malta - engelsk - Medicines Authority

csl behring gmbh emil-von-behring-strasse 76, 35041 marburg, germany - human albumin, solution - solution for infusion - human albumin solution 200 g/l - blood substitutes and perfusion solutions

Malta - engelsk - Medicines Authority

csl behring gmbh emil-von-behring-strasse 76, 35041 marburg, germany - human albumin, solution - solution for infusion - human albumin solution 200 g/l - blood substitutes and perfusion solutions